FDA Approves Albuterol Sulfate ANDA219409 from Cipla
The FDA has approved ANDA219409 for Albuterol Sulfate submitted by Cipla.
Therapeutic Area
Therapeutic area intelligence for Bronchodilator with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.